October 8th, 2025 01:00 PM EST
Presented by: Shailesh Vengurlekar – SVP of Quality & Regulatory Affairs, LGM Pharma Diem Hoang – Director of Quality, LGM Pharma
503A pharmacies and 503B outsourcing facilities face rising expectations around compliance, product quality, and turnaround time – often with limited internal lab capabilities. Whether working with sterile injectables, ophthalmics, or complex non-sterile formulations, the right analytical testing strategy can mean the difference between smooth operations and costly delays.
Join leadership from LGM Pharma’s Quality Division for a focused 30-minute session exploring how contract analytical testing can help compounders navigate these challenges.
This session will provide practical guidance on:
- Microbiological testing per USP <61>, <62>, <71>, and <85>
- Batch release testing, method verification, and content uniformity (USP <905>)
- Rapid sterility testing and strategies to shorten turnaround times
- Compliance with USP <795>, <797>, and <800> and their analytical implications
Attendees will leave with actionable insights on how to ensure compliance, improve quality, and choose the right testing partner for both routine needs and strategic support. Register Now >
